Written by Klarity Editorial Team
Published: Jul 17, 2026

Last updated: July 17, 2026
Quick Summary: Cigna health plans in Hawaii may cover anxiety treatment including therapy, psychiatric evaluations, and anxiety medications. Cigna uses Express Scripts (ESI) as its pharmacy benefit manager (PBM) — a different formulary from HMSA and Aetna in Hawaii (both use CVS Caremark). Most first-line anxiety medications such as SSRIs, SNRIs, buspirone, and hydroxyzine are typically available at Tier 1–2 with no prior authorization required. Importantly, Cigna’s PA policy IP0477 applies to stimulants only and does not affect anxiety medications. Under Hawaii’s Electronic Prescribing for Controlled Substances law (HRS § 329-38.5), no commonly prescribed anxiety medication requires electronic prescribing in Hawaii — even benzodiazepines (Schedule IV) and pregabalin (Schedule V) fall outside the Schedule II-only mandate.
If you have Cigna insurance in Hawaii and are seeking anxiety treatment, understanding your coverage is an important first step. Cigna’s behavioral health benefits in Hawaii are governed by Hawaii’s mental health parity law (Haw. Rev. Stat. § 431M-1 et seq.) and, for employer-sponsored plans, by the federal Mental Health Parity and Addiction Equity Act (MHPAEA). This guide covers the ESI formulary for anxiety medications, prior authorization requirements, Hawaii EPCS rules, and how to verify your specific benefits.
Considering anxiety treatment? Klarity Health connects you with 2,000+ licensed providers — many accepting Cigna insurance. See if you may qualify →
Cigna offers commercial health plans in Hawaii — including HMO, PPO, and employer-sponsored plans — with behavioral health benefits that may cover anxiety treatment. Coverage for anxiety-related services typically includes:
The scope of coverage depends on your specific plan, network tier, deductible, and whether the provider is in-network. Always verify your benefits by calling Cigna Member Services at 1-800-244-6224 or logging in to myCigna.com before scheduling services.
Cigna uses Express Scripts (ESI) as its pharmacy benefit manager in Hawaii — distinct from HMSA and Aetna, which both use CVS Caremark. The ESI formulary has a different tier structure and prior authorization criteria. The table below reflects typical ESI commercial formulary placement for anxiety medications; your specific plan tier and copay may vary.
| Medication | Type | ESI Tier | PA Required? | Notes |
|---|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Tier 1 | No | First-line; preferred generic |
| Escitalopram (generic Lexapro) | SSRI | Tier 1 | No | First-line; preferred generic |
| Fluoxetine (generic Prozac) | SSRI | Tier 1 | No | First-line; preferred generic |
| Paroxetine (generic Paxil) | SSRI | Tier 1–2 | Rarely | Extended-release may differ |
| Venlafaxine ER (generic Effexor XR) | SNRI | Tier 1–2 | Rarely | First-line SNRI; preferred generic |
| Duloxetine (generic Cymbalta) | SNRI | Tier 1–2 | Rarely | Approved for GAD |
| Buspirone (generic BuSpar) | Anxiolytic | Tier 1 | No | Non-controlled; preferred for GAD |
| Hydroxyzine (Vistaril/Atarax) | Antihistamine anxiolytic | Tier 1 | No | Non-controlled; often used as-needed |
| Propranolol (generic) | Beta-blocker (off-label) | Tier 1–2 | No | Off-label for situational anxiety; check plan |
| Brand Lexapro (escitalopram) | SSRI — brand | Tier 3–4 | Step therapy | Generic required first |
| Effexor XR (venlafaxine ER — brand) | SNRI — brand | Tier 3–4 | Step therapy | Generic required first |
| Lorazepam (generic Ativan) | Benzodiazepine (Sched. IV) | Tier 2 | No (QL) | Quantity limits apply; Schedule IV — NOT subject to HI EPCS |
| Clonazepam (generic Klonopin) | Benzodiazepine (Sched. IV) | Tier 2 | No (QL) | Quantity limits apply; Schedule IV — NOT subject to HI EPCS |
| Alprazolam (generic Xanax) | Benzodiazepine (Sched. IV) | Tier 2 | No (QL) | Quantity limits apply; Schedule IV — NOT subject to HI EPCS |
| Pregabalin (generic Lyrica) | Anticonvulsant (Sched. V) | Tier 2–3 | Sometimes | Schedule V — NOT subject to HI EPCS |
Formulary placement is based on typical ESI commercial formulary tiers as of 2026. Individual plan designs may vary. Verify your specific coverage at express-scripts.com or by calling ESI at 1-800-835-3784.
No — Cigna’s PA policy IP0477 does not apply to anxiety medications. IP0477 (effective May 15, 2026) is a Cigna-specific prior authorization policy that requires PA for all stimulant medications — including generic stimulants that were previously PA-free. This policy was designed for ADHD treatment (stimulants such as amphetamine salts, methylphenidate, lisdexamfetamine) and is not applicable to the anxiety medication classes described in this guide.
SSRIs, SNRIs, buspirone, hydroxyzine, benzodiazepines, and pregabalin are not stimulant medications and are not subject to IP0477. Most first-line anxiety medications may be dispensed without prior authorization under the standard ESI formulary rules for Cigna commercial plans in Hawaii.
If you have questions about whether a specific medication requires PA under your Cigna plan, contact Cigna Member Services at 1-800-244-6224 or log in to myCigna.com to check your benefit details.
While most first-line anxiety medications do not require prior authorization, some situations may trigger a PA request under the ESI formulary:
PA requests for anxiety medications through Cigna are submitted via Availity (availity.com) or cigna.com/providers. Standard PA decisions are typically made within 2–3 business days; urgent requests involving clinical necessity may be expedited within 24–72 hours.
To initiate a PA for an anxiety medication, your Cigna provider will need: the diagnosis (ICD-10 code), the requested medication and strength, documentation of prior treatments tried (for step therapy), and the clinical rationale for the requested medication.
Hawaii’s Electronic Prescribing for Controlled Substances (EPCS) law — codified at Haw. Rev. Stat. § 329-38.5 — requires electronic prescribing for Schedule II controlled substances only. This is a narrower mandate than some other states (notably West Virginia, where W. Va. Code § 60A-4-403a covers all controlled substances including Schedule IV and V).
Here is how the Hawaii EPCS mandate applies to commonly prescribed anxiety medications:
In practical terms, no commonly prescribed anxiety medication requires electronic prescribing under Hawaii law. Even controlled substances used in anxiety treatment (benzodiazepines, pregabalin) are exempt from the HRS § 329-38.5 EPCS requirement because they are Schedule IV and V, not Schedule II.
This contrasts with West Virginia’s broader EPCS rule (W. Va. Code § 60A-4-403a), where Schedule IV benzodiazepines and Schedule V pregabalin both trigger EPCS requirements. Hawaii’s narrower Schedule II-only mandate means prescribers face no additional EPCS compliance burden when prescribing anxiety medications to Cigna members in Hawaii.
Cigna commercial health plans in Hawaii are subject to Haw. Rev. Stat. § 431M-1 et seq., Hawaii’s mental health parity law, which requires that mental health and substance use disorder (MH/SUD) benefits be provided on no less favorable terms than medical/surgical benefits. This means:
ERISA carve-out: Self-funded employer-sponsored plans (common among large employers in Hawaii) are governed by ERISA and are exempt from the Hawaii state parity statute. However, these plans are still subject to the federal MHPAEA, which provides comparable protections. If you are unsure whether your Cigna plan is state-regulated or self-funded, contact the Hawaii Insurance Division at 1-808-586-2790.
If you believe Cigna has violated parity requirements in denying or limiting your anxiety treatment coverage, you have the right to file a complaint with the Hawaii Insurance Division or to request an internal appeal and, if applicable, an independent external review.
Hawaii’s Prepaid Health Care Act (Haw. Rev. Stat. § 393) is a unique employer health insurance mandate that requires employers to provide health insurance coverage to employees working 20 or more hours per week for four consecutive weeks. This law predates the Affordable Care Act and gives Hawaii one of the most comprehensive employer coverage requirements in the United States.
For anxiety treatment coverage, the practical effect is that most Hawaii residents working 20+ hours per week at a qualifying employer may already be covered through an employer-sponsored plan — and Cigna is one of the carriers that offers plans meeting this mandate. Employees enrolled through their employer in a Cigna plan subject to HRS § 393 benefit from the same parity protections and formulary access described in this guide.
If you have questions about whether your employer’s plan meets the Hawaii Prepaid Health Care Act requirements, contact the Hawaii Department of Labor and Industrial Relations (DLIR) at 1-808-586-8777.
Cigna behavioral health coverage in Hawaii may extend to the following anxiety-related diagnoses (subject to your specific plan and medical necessity criteria):
Coverage decisions are based on medical necessity criteria. Cigna typically applies InterQual or its own clinical guidelines when evaluating coverage for behavioral health services. Your provider may be asked to document the diagnosis, treatment history, and clinical rationale when requesting coverage for intensive or high-cost services.
Ready to get started? Klarity Health works with 2,000+ licensed providers — including many who accept Cigna insurance in Hawaii. Check if you may qualify →
Klarity Health is a telehealth platform with a network of 2,000+ licensed providers, including psychiatrists, nurse practitioners, and therapists, who provide anxiety treatment via secure video visits. Many providers on the Klarity platform may accept Cigna insurance. Services available through Klarity for anxiety treatment may include:
Coverage varies by individual plan. Patients are encouraged to verify their Cigna benefits before booking. Learn more about Klarity’s anxiety treatment services →
Cigna commercial plans in Hawaii typically cover outpatient individual therapy for anxiety disorders when provided by an in-network licensed therapist or psychologist. Hawaii’s mental health parity law (Haw. Rev. Stat. § 431M-1 et seq.) generally requires that mental health benefits be provided on no less favorable terms than medical/surgical benefits. Coverage may vary by plan, network tier, and whether services meet Cigna’s medical necessity criteria. Verify your specific benefits at myCigna.com or by calling 1-800-244-6224.
No. Cigna’s IP0477 policy (effective May 15, 2026) requires prior authorization for stimulant medications used to treat ADHD — it does not apply to anxiety medications. SSRIs, SNRIs, buspirone, hydroxyzine, benzodiazepines, and pregabalin are not subject to IP0477. Most first-line anxiety medications may be dispensed under standard ESI formulary rules without additional PA requirements associated with IP0477.
This depends on your specific Cigna plan type. HMO plans typically require a referral from your primary care physician (PCP) before seeing a specialist, including a psychiatrist. PPO and Open Access Plus plans generally allow you to see in-network mental health providers without a referral. Check your plan documents or call Cigna at 1-800-244-6224 to confirm your referral requirements.
No. Benzodiazepines such as alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin) are Schedule IV controlled substances. Hawaii’s EPCS law (HRS § 329-38.5) applies to Schedule II controlled substances only. Schedule IV benzodiazepines are not subject to the Hawaii electronic prescribing mandate, meaning your Cigna provider in Hawaii may issue paper or electronic prescriptions for these medications without triggering a mandatory EPCS requirement. (Note: West Virginia requires EPCS for all controlled substances including Schedule IV, but Hawaii’s rule is narrower.)
If Cigna denies a claim or PA request for anxiety treatment, you have several options. First, request a written explanation of the denial and the specific criteria that were not met. Then file an internal appeal with Cigna — appeals for mental health benefits may be strengthened by citing Hawaii’s parity law (Haw. Rev. Stat. § 431M-1 et seq.), which requires that MH/SUD benefits be provided on terms no more restrictive than comparable medical/surgical benefits. If your internal appeal is denied, you may request an independent external review. You may also file a complaint with the Hawaii Insurance Division at 1-808-586-2790 or insurance.hawaii.gov.
The Hawaii Prepaid Health Care Act (HRS § 393) requires employers to provide health coverage to employees working 20+ hours per week, which means most Cigna enrollees in Hawaii obtained their coverage through their employer’s obligation under this law. The Act ensures broad access to employer-sponsored plans in Hawaii. Once enrolled in a Cigna plan, your mental health benefits — including anxiety treatment — are subject to Hawaii parity law (§ 431M-1) and federal MHPAEA. For questions about whether your employer plan meets the Act’s requirements, contact the Hawaii DLIR at 1-808-586-8777.
Disclaimer: This guide is for general informational purposes only and does not constitute insurance, legal, or medical advice. Coverage for anxiety treatment varies by individual Cigna plan, employer agreement, network participation, and medical necessity criteria. References to formulary tiers, PA requirements, and benefit structures reflect typical ESI and Cigna commercial plan designs as of 2026 and may not apply to every plan. Always verify your specific benefits with Cigna at 1-800-244-6224 or myCigna.com before scheduling services or filling prescriptions. Klarity Health does not guarantee insurance coverage for any individual patient.
Find the right provider for your needs — select your state to find expert care near you.